EPA outlined the Endocrine Disruptor Screening Program (EDSP), which is one outcome of the FQPA Act of 1996 requiring development of a program to determine if the effect that certain substances have in humans is similar to the effect produced by a naturally occurring hormone.
View Source
Timeline Stories